Home › Heart Attack › Tennessee › Memphis
Heart Attack clinical trials in Memphis, TN
3 studies for Heart Attack are looking for participants at sites in and around Memphis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
RecruitingPhase 2/3
- Lt. Col. Luke Weathers, Jr. VA Medical Center, Memphis
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
RecruitingPhase 3
- Stern Cardiovascular Foundation Inc, Southaven · 11 mi away
- The Stern Cardiovascular Foundation, Germantown · 14 mi away
Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
Recruiting
- University of Tennessee Health Science Center/Regional One Health, Memphis
About Heart Attack
A heart attack happens when the blood flow to the heart gets blocked. It causes heart damage and is a medical emergency. Know the symptoms and when to call 911.
More about Heart Attack on MedlinePlus
Heart Attack trials in other cities
- Rochester, MN6 studies
- Dallas, TX6 studies
- New York City, NY6 studies
- Boston, MA5 studies
- Nashville, TN4 studies
- Detroit, MI4 studies
- Hartford, CT4 studies
- Los Angeles, CA4 studies
- Houston, TX4 studies
- Knoxville, TN4 studies
- Boca Raton, FL4 studies
- Raleigh, NC3 studies
Other studies in Memphis
- Cancer (all types)31 studies
- Non-Small Cell Lung Cancer23 studies
- Breast Cancer21 studies
- Lung Cancer18 studies
- Sickle Cell Disease18 studies
- Acute Lymphoblastic Leukemia16 studies
- Acute Myeloid Leukemia15 studies
- Heart Failure13 studies
- Colorectal Cancer11 studies
- Melanoma11 studies
- Soft Tissue Sarcoma11 studies
- Prostate Cancer11 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.